Advertisement

Topics

Massachusetts Life Science M&A Hits $22.5 Billion So Far This Year

20:00 EDT 9 Jul 2019 | BioSpace

As the largest center for biotech startups in the U.S., the Boston/Cambridge, Massachusetts area often acts as a marker for the entire industry. Although merger-and-acquisition numbers are reportedly down from last year, the value is actually higher. Here’s a look at the Massachusetts deals so far.

Original Article: Massachusetts Life Science M&A Hits $22.5 Billion So Far This Year

NEXT ARTICLE

More From BioPortfolio on "Massachusetts Life Science M&A Hits $22.5 Billion So Far This Year"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...